64 related articles for article (PubMed ID: 8554956)
21. Future directions in stroke management.
Hankey GJ
Aust Fam Physician; 1991 Nov; 20(11):1627, 1630-8. PubMed ID: 1785984
[TBL] [Abstract][Full Text] [Related]
22. Management of acute stroke. Ways to minimize damage and maximize recovery.
Pryse-Phillips W; Yegappan MC
Postgrad Med; 1994 Oct; 96(5):75-6, 79-82, 85. PubMed ID: 7937421
[TBL] [Abstract][Full Text] [Related]
23. [Nootropic drugs in the acute period of cerebral stroke].
Zinchenko VA; Palaguta VD; Sytinskiĭ IA
Vrach Delo; 1985 Jan; (1):85-6. PubMed ID: 3984336
[No Abstract] [Full Text] [Related]
24. William M. Feinberg Lecture: stroke therapy in the year 2025: burden, breakthroughs, and barriers to progress.
Broderick JP
Stroke; 2004 Jan; 35(1):205-11. PubMed ID: 14671248
[TBL] [Abstract][Full Text] [Related]
25. Hypothesis for rational therapy in acute stroke.
Kogure K; Scheinberg P; Kishikawa H; Busto R; Reinmuth OM
Trans Am Neurol Assoc; 1976; 101():160-4. PubMed ID: 1028224
[No Abstract] [Full Text] [Related]
26. Therapeutic interventions in acute stroke.
Lees KR
Br J Clin Pharmacol; 1992 Dec; 34(6):486-93. PubMed ID: 1493080
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic progress--review XXIII. Are we making progress in the treatment of acute stroke?
Hill S; Main A
J Clin Hosp Pharm; 1986 Dec; 11(6):427-41. PubMed ID: 3546385
[TBL] [Abstract][Full Text] [Related]
28. Drug treatment of stroke. Current status and future prospects.
Sila CA; Furlan AJ
Drugs; 1988 Apr; 35(4):468-76. PubMed ID: 3292210
[TBL] [Abstract][Full Text] [Related]
29. From neuroplastic potential to actual recovery after stroke: a call for cooperation between drugs and exercise.
Tesio L
Aging (Milano); 1991 Mar; 3(1):97-8. PubMed ID: 2065134
[No Abstract] [Full Text] [Related]
30. Restorative neurology. Drugs and recovery following stroke.
Goldstein LB; Davis JN
Stroke; 1990 Nov; 21(11):1636-40. PubMed ID: 2237961
[No Abstract] [Full Text] [Related]
31. Forecasting pushed too far.
Kerr RA
Science; 1989 Jun; 244(4909):1139. PubMed ID: 17757420
[No Abstract] [Full Text] [Related]
32. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
33. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
34. Beware the Medical-Industrial Complex.
Stevens CW; Glatstein E
Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological therapy for acute stroke: the future.
Panayiotou BN; Fotherby MD
Br J Clin Pract; 1995; 49(6):314-7. PubMed ID: 8554956
[TBL] [Abstract][Full Text] [Related]
36. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
37. Naftidrofuryl after acute stroke: a review and a hypothesis.
Steiner TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S58-61. PubMed ID: 1369721
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
